FULGENT GENETICS, INC. Comprehensive Income
FULGENT GENETICS, INC. (FLGT) reported Comprehensive Income of -$32.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$32.15M.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$27.80M.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$22.73M.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$5.78M.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$52.63M.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$44.28M.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$145.72M, a 218.22% decline from fiscal 2022.
- FULGENT GENETICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $123.26M, a 75.65% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$32.15M 10-Q · filed 2026-07-30 | -$59.95M 10-Q · filed 2026-07-30 | -$82.68M derived: sum of 3 quarters · filed 2026-07-30 | -$88.46M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$27.80M 10-Q · filed 2026-05-01 | -$50.53M derived: sum of 2 quarters · filed 2026-05-01 | -$56.31M derived: sum of 3 quarters · filed 2026-05-01 | -$73.61M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$22.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$28.51M derived: sum of 2 quarters · filed 2026-02-27 | -$45.81M derived: sum of 3 quarters · filed 2026-07-30 | -$52.63M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$5.78M 10-Q · filed 2025-11-07 | -$23.08M derived: sum of 2 quarters · filed 2026-07-30 | -$29.90M 10-Q · filed 2025-11-07 | -$45.34M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$17.29M 10-Q · filed 2026-07-30 | -$24.12M 10-Q · filed 2026-07-30 | -$39.55M derived: sum of 3 quarters · filed 2026-07-30 | -$44.15M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$6.83M 10-Q · filed 2026-05-01 | -$22.26M derived: sum of 2 quarters · filed 2026-05-01 | -$26.85M derived: sum of 3 quarters · filed 2026-05-01 | -$35.34M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$15.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$20.03M derived: sum of 2 quarters · filed 2026-02-27 | -$28.51M derived: sum of 3 quarters · filed 2026-02-27 | -$44.28M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$4.59M 10-Q · filed 2025-11-07 | -$13.08M derived: sum of 2 quarters · filed 2025-11-07 | -$28.85M 10-Q · filed 2025-11-07 | -$138.90M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$8.48M 10-Q · filed 2025-08-01 | -$24.25M 10-Q · filed 2025-08-01 | -$134.31M derived: sum of 3 quarters · filed 2026-02-27 | -$143.56M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$15.77M 10-Q · filed 2025-05-02 | -$125.82M derived: sum of 2 quarters · filed 2026-02-27 | -$135.07M derived: sum of 3 quarters · filed 2026-02-27 | -$149.85M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$110.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$119.31M derived: sum of 2 quarters · filed 2026-02-27 | -$134.08M derived: sum of 3 quarters · filed 2026-02-27 | -$145.72M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$9.25M 10-Q · filed 2024-11-08 | -$24.03M derived: sum of 2 quarters · filed 2024-11-08 | -$35.66M 10-Q · filed 2024-11-08 | -$54.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$14.78M 10-Q · filed 2024-08-02 | -$26.41M 10-Q · filed 2024-08-02 | -$45.55M derived: sum of 3 quarters · filed 2025-02-28 | -$47.01M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$11.63M 10-Q · filed 2024-05-03 | -$30.77M derived: sum of 2 quarters · filed 2025-02-28 | -$32.23M derived: sum of 3 quarters · filed 2025-02-28 | -$30.62M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$19.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$20.60M derived: sum of 2 quarters · filed 2025-02-28 | -$18.99M derived: sum of 3 quarters · filed 2025-02-28 | $123.26M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$1.47M 10-Q · filed 2023-11-03 | $147.00K derived: sum of 2 quarters · filed 2023-11-03 | $142.39M 10-Q · filed 2023-11-03 | $246.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.61M 10-Q · filed 2023-08-04 | $143.86M 10-Q · filed 2023-08-04 | $247.65M derived: sum of 3 quarters · filed 2024-02-28 | $370.23M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $142.25M 10-Q · filed 2023-05-05 | $246.04M derived: sum of 2 quarters · filed 2024-02-28 | $368.61M derived: sum of 3 quarters · filed 2024-02-28 | $448.38M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $103.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $226.37M derived: sum of 2 quarters · filed 2024-02-28 | $306.13M derived: sum of 3 quarters · filed 2024-02-28 | $506.17M 10-K · filed 2024-02-28 |
| 2021-09-30 | $122.58M 10-Q · filed 2022-11-07 | $202.34M derived: sum of 2 quarters · filed 2022-11-07 | $402.38M 10-Q · filed 2022-11-07 | $568.51M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $79.76M 10-Q · filed 2022-08-04 | $279.80M 10-Q · filed 2022-08-04 | $445.94M derived: sum of 3 quarters · filed 2023-02-28 | $492.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $200.04M 10-Q · filed 2022-05-05 | $366.18M derived: sum of 2 quarters · filed 2023-02-28 | $412.37M derived: sum of 3 quarters · filed 2023-02-28 | $416.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $166.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $212.33M derived: sum of 2 quarters · filed 2023-02-28 | $216.90M derived: sum of 3 quarters · filed 2023-02-28 | $214.60M 10-K · filed 2023-02-28 |
| 2020-09-30 | $46.20M 10-Q · filed 2021-11-09 | $50.76M derived: sum of 2 quarters · filed 2021-11-09 | $48.46M 10-Q · filed 2021-11-09 | $48.13M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $4.56M 10-Q · filed 2021-08-10 | $2.27M 10-Q · filed 2021-08-10 | $1.94M derived: sum of 3 quarters · filed 2022-02-28 | $3.38M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$2.29M 10-Q · filed 2021-05-07 | -$2.62M derived: sum of 2 quarters · filed 2022-02-28 | -$1.19M derived: sum of 3 quarters · filed 2022-02-28 | -$747.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.11M derived: sum of 2 quarters · filed 2022-02-28 | $1.55M derived: sum of 3 quarters · filed 2022-02-28 | -$230.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.44M 10-Q · filed 2020-11-09 | $1.88M derived: sum of 2 quarters · filed 2020-11-09 | $99.00K 10-Q · filed 2020-11-09 | -$1.93M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $439.00K 10-Q · filed 2020-08-05 | -$1.34M 10-Q · filed 2020-08-05 | -$3.37M derived: sum of 3 quarters · filed 2020-08-05 | -$3.94M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$1.78M 10-Q · filed 2020-05-06 | -$3.81M derived: sum of 2 quarters · filed 2020-05-06 | -$4.38M derived: sum of 3 quarters · filed 2020-05-06 | -$5.42M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$2.60M derived: sum of 2 quarters · filed 2020-03-13 | -$3.65M derived: sum of 3 quarters · filed 2020-03-13 | -$5.60M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$570.00K 10-Q · filed 2019-11-08 | -$1.61M derived: sum of 2 quarters · filed 2019-11-08 | -$3.57M 10-Q · filed 2019-11-08 | -$5.25M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | -$1.04M 10-Q · filed 2019-08-12 | -$3.00M 10-Q · filed 2019-08-12 | -$4.67M derived: sum of 3 quarters · filed 2019-08-12 | -$5.69M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | -$1.95M 10-Q · filed 2019-05-10 | -$3.63M derived: sum of 2 quarters · filed 2019-05-10 | -$4.65M derived: sum of 3 quarters · filed 2019-05-10 | -$4.65M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$2.69M derived: sum of 2 quarters · filed 2019-03-22 | -$2.70M derived: sum of 3 quarters · filed 2019-03-22 | -$2.45M 10-K · filed 2019-03-22 |
| 2017-09-30 | -$1.01M 10-Q · filed 2018-11-09 | -$1.02M derived: sum of 2 quarters · filed 2018-11-09 | -$773.00K 10-Q · filed 2018-11-09 | -$99.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$8.00K 10-Q · filed 2018-08-13 | $242.00K 10-Q · filed 2018-08-13 | $916.00K derived: sum of 3 quarters · filed 2018-08-13 | -$191.00K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $214.00K 10-Q · filed 2018-05-14 | $924.00K derived: sum of 2 quarters · filed 2018-05-14 | -$183.00K derived: sum of 3 quarters · filed 2018-05-14 | -$4.69M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$397.00K derived: sum of 2 quarters · filed 2018-03-20 | -$4.91M derived: sum of 3 quarters · filed 2018-03-20 | -$5.45M 10-K · filed 2018-03-20 |
| 2016-09-30 | -$1.11M 10-Q · filed 2017-11-13 | -$5.62M derived: sum of 2 quarters · filed 2017-11-13 | -$6.16M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$4.51M 10-Q · filed 2017-08-14 | -$5.05M 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$543.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | -$8.31M 10-K · filed 2017-03-17 | |||
| 2014-12-31 | -$4.28M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |